XENOBREX

This brand name is authorized in Nigeria.

Active ingredients

The drug XENOBREX contains one active pharmaceutical ingredient (API):

1	Celecoxib UNII JCX84Q7J1L - CELECOXIB
	Celecoxib is an oral, selective, cyclooxygenase-2 (COX-2) inhibitor within the clinical dose range (200-400 mg daily). No statistically significant inhibition of COX-1 (assessed as ex vivo inhibition of thromboxane B2 [TxB2] formation) was observed in this dose range in healthy volunteers.
	Read more about Celecoxib

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-8436	Capsule	Xenobrex Capsules 200mg CAP 200 mg 1 X 10 Capsules	59 RNW-PP-319472 Xenobrex Capsules 200mg CELECOXIB 200mg CELECOXIB 200MG (Excipient: Lactose Monohydrate (Granulac 230), Croscarmellose Sodium (AC- DI -SOL SD 711), Povidone (PVP K30) , Sodium Lauryl Sulphate (Texapon), Magnesium Stearate) B4-8436 Drugs Imported Products 1X10CAPSULES POM 1 4/4/2023 BOCHEPHARM NIGERIA LIMITED, 41B, Iwaya Road, Yaba 8129238605 bochepharm2019@outlook.com CELOGEN GENERICS PVT. LTD. , Plot No. 646/1&2, Agrawal Industrial Estate, Somnath Temple Road, Dabhel, Daman - 396 210, U.T. , India	30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AH01	Celecoxib	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AH Coxibs
Discover more medicines within M01AH01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-8436